Drug profile · INN
elranatamab
ELREXFIO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
elranatamab (ELREXFIO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN elranatamab
Brand ELREXFIO
Route INJECTION
Formulation SOLUTION
Frequently asked questions
What is elranatamab?
elranatamab (ELREXFIO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for elranatamab?
ELREXFIO is a marketed brand name for elranatamab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of elranatamab?
elranatamab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.